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Woman with a Bleeding Diathesis
Bo Kim MD, PGY-3

61 year-old Indian female with history of hypercholesterolemia presents to an outside hospital (OSH) with
worsening vaginal bleeding, hematochezia, nausea, and
vomiting starting three days prior to admission. Patient
also had a global persistent headache for approximately
24 hours at the time of admission. Otherwise, the patient
denied any fever, chills, abdominal pain, or trauma. The
patient noted no previous episodes of bleeding or easy
bruising in her past. She notes that her menstrual periods
were always regular and not subjectively heavy. Last
menstrual period was 10 years ago. Patient has had two
pregnancies in her obstetric history for which she
delivered vaginally without bleeding complications. The
patient denied recent antibiotic use. She had no change
in diet and no prior transfusions. At the OSH, the
patient was noted to be orthostatic at presentation with
mild tachycardia but was stabilized with intravenous
fluids and transfusions of packed red cells. Patient’s
nausea and vomiting resolved with antiemetics at the
OSH. Nasogastric lavage was negative for blood.
Laboratory results revealed patient to have markedly
elevated prothrombin time (PT) and activated partial
thromboplastin time (aPTT) with an INR greater than
20. The patient was initially treated with fresh frozen
plasma (FFP) and high doses of vitamin K. The patient
denied any warfarin use and she did not know anyone
currently on the medication. CT scan of the head showed
left subdural hematoma without midline shift or
hydrocephalus. The patient was immediately transferred
to the Jefferson Neurosurgical service. The patient was
subsequently deemed a poor surgical candidate and was
continued on supportive treatment with blood products
and vitamin K. At time of transfer to the medicine
service, the patient developed respiratory distress with
severe hypoxia requiring intubation. The patient was
admitted to the intensive care unit (ICU) for ventilatordependent respiratory failure secondary to Transfusion
Related Acute Lung Injury (TRALI). After five days, the
patient was extubated and transferred to the medicine
floor team in stable condition for further management
of her bleeding diathesis.
The patient’s past medical history was significant only
for hypercholesterolemia but the patient was on no
medications. The patient had a cholecystectomy 12 years
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ago and a laminectomy 7 years ago. Psychiatric history
was notable for depression with prior suicide attempt five
years prior to admission. Family history was negative for
any bleeding disorder or malignancy. Social history
revealed no alcohol use, substance use, or smoking. The
patient was a homemaker.
On physical exam after transfer from the ICU, the
patient was afebrile with a pulse of 85 beats per minute,
a respiratory rate of 16 breaths per minute, and a blood
pressure of 132/72mmHg. In general, the patient was in
no acute distress. She was well nourished, well developed,
and appeared her stated age. The patient’s head was
normocephalic and atraumatic. Her eyes showed equally
round and reactive to light pupils and anicteric sclera.
Her extra-ocular muscles were intact. Her mucous
membranes were moist, her oropharynx was clear, and
there were no petechiae or stomatitis in the oral cavity.
Her neck was supple with no lymphadenopathy, no
thyromegaly, no JVD or carotid bruits. Her heart was
regular with no murmurs, gallops, or rubs. Her lungs
had minimal scattered bilateral rales and mild bibasilar
crackles. Her abdomen was soft, non-distended, nontender. There were no appreciable masses or
organomegaly. Her rectal exam revealed moderate
external hemorrhoids. There was normal rectal tone,
stool was dark brown and heme positive. There was no
frank blood. There was no clubbing, cyanosis, or edema
in the extremities. Her neurologic exam revealed no focal
deficits with cranial nerves II-XII grossly intact. There
was also no nystagmus, no dysmetria on finger to nose,
and deep tendon reflexes were equal and symmetric. Her
skin revealed small ecchymoses on upper extremities. See
Table 1 for the baseline laboratories at time of transfer to
the medicine floor service.
The remainder of the hospital course was notable for the
continued elevations in her PT. Multiple transfusions of
FFP and multiple injections of high-dose vitamin K
initially normalized the PT and aPTT at the time of
transfer from the neurosurgical service. Subsequent
coagulation labs revealed a continually rising PT
requiring the titration of the vitamin K dose from 10mg
daily to 50mg twice daily. For two weeks, the patient had
high doses of vitamin K and any dose
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Table 1.
Laboratory Test
White blood cells
Hemoglobin
Hematocrit
Platelet count
Sodium
Potassium
Chloride
Bicarbonate
BUN
Creatinine
Glucose
Protein
Albumin
Total biliribuin
AST
ALT
Alkaline phosphatase
PT
INR
aPTT

Table 2.
Laboratory Value
6.7
9.3
28.3
212
147
3.7
111
29
8.0
0.9
104
7.0
4.0
0.9
26
21
80
24.6
2.08
38.0

taper led to a rapid rise in PT (See Table 2). The platelet
count remained stable and hemolysis labs were negative.
Her DIC panel revealed a mildly elevated D-dimer and
a markedly elevated fibrinogen. Mixing studies
performed on the second day of admission revealed
normalization of elevated coagulation factors with
mixing indicating a deficiency of factors rather than a
presence of an inhibitor. Despite the elevated PT, there
was no further evidence of active bleeding during the
remainder of the hospitalization. Repeat head CT
revealed a slowly resolving subdural hematoma and the
hemoglobin remained stable. The patient was seen by
gynecology and gastroenterology but no active
interventions were planned as an inpatient.
Of concern was the patient’s psychiatric history with a
prior suicide attempt. The patient was initially placed on
one to one nursing especially given the continuing
elevations in her hemostatic labs. The patient repeatedly
denied depression or suicidal ideations. She was evaluated
by the psychiatry department at Jefferson and was deemed
safe for discharge home. Approximately one month after
discharge, the patient’s PT was stable on oral vitamin K.

Day 1

Day 2

Day 3

Day 4

Day 6

Day 7

Day 31 Day 32

PT

12.6

29.1

18.2

25.2

24.6

31.7

14.6

14.6

INR

1.0

3.47

2.45

5.17

2.08

2.88

1.07

1.07

aPTT

41.3

40.9

43.6

46.1

38

45

40mg

50mg

100mg 100mg 20mg** 20mg**

PT mix

13.1

aPTT mix

32.7

Daily Vit
K dose 10mg

20mg

* Transfer to the medicine floor

**Oral dose

Discussion
The history and presentation of the patient suggest a
diagnosis of an acquired hemostatic disorder rather than
an inherited or congenital disease. The patient did not
have any memorable episodes of bleeding in her past and
no one in her family had a problem with bleeding that
she could report. Acquired bleeding diathesis can be
categorized into two major categories, platelet defect
versus coagulation disorder.
A quantitative platelet disorder can induce bleeding
usually with platelet counts below 50,000. Diseases such
as idiopathic thrombocytopenic purpura (ITP),
thrombotic thrombocytopenic purpura (TTP), or
heparin induced thrombocytopenia (HIT) can
precipitously drop the platelet count. The patient did
not have a significant decline in her platelet count, nor
did she show any clinical signs of TTP (mental status
changes, fever, renal failure, hemolytic anemia). The
patient had also never been on heparin. A qualitative
platelet dysfunction can be medication-induced (ASA,
NSAIDs, clopidogrel, ticlopidine), or associated with a
medical condition such as uremia, myelodysplastic
syndrome (MDS), or von Willebrand disease (VWD).
The patient was not on any medications and had good
renal function. The diagnosis of MDS can be one of
exclusion especially when an elderly patient presents with
anemia (typically macrocytic) or pancytopenia with no
clear etiology. Diagnosis was not pursued because of low
clinical suspicion and a bone marrow biopsy was clearly
not indicated in this case. VWD is the most common
inherited bleeding disorder with a prevalence of
approximately 1%. A negative family history does not
rule out VWD since the clinical presentation can be
variable and subclinical. Most women with milder VWD
(Continued on next page)
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will usually report heavy menstrual periods and postpartum bleeding. The patient presented with heavy
bleeding for three days of sudden onset. Inherited VWD
would be very unlikely in this case since more severe
forms of VWD would manifest at a much earlier age.
Acquired VWD is a possibility but the disorder is
associated with comorbidities such as malignancies and
autoimmune disorders that were not evident in the
patient. Furthermore, VWD can cause an elevation of
the aPTT because it is the carrier of factor VIII, but it
will not cause critical elevations of PT and aPTT.
Ristocetin cofactor assay to test qualitative function of
von Willebrand factor was not performed.
Acquired coagulation disorders with elevated PT and
aPTT can be caused by liver disease, deficiency or
inhibitors to factor V or X, deficiency of fibrinogen or
prothrombin, disseminated intravascular coagulation
(DIC), or high doses of warfarin with or without
heparin. Vitamin K deficiency alone would not cause
elevations in aPTT. The patient had normal liver
function and had mixing studies that normalized during
the hospitalization. A mixing study mixes the plasma of
the patient with elevations in PT or aPTT with plasma
that has normal coagulation function. A normalization
of the coagulation labs would indicate a deficiency of
factors that were replaced by the normal plasma whereas
a continued elevation in PT or aPTT would indicate the
presence of an inhibitor (antibody or medication). Acute
DIC is most commonly associated with trauma, sepsis,
or malignancy and treatment is aimed at the underlying
cause. Supportively, the patient can be treated with FFP
or cryoprecipitate if the fibrinogen is low. The patient
only had a mild elevation in the D-dimer (fibrin
degradation product) and elevation in fibrinogen (acute
phase reactant). There was no evidence of hemolysis and
the platelet count was stable.
The marked elevations in the PT and aPTT that
responded to vitamin K are most consistent with
warfarin toxicity. The patient denied any use of the
medication and she could not have ingested the drug
accidentally. Also concerning was the difficulty of
normalizing her coagulation defect even weeks after the
inciting event. Rodenticides are warfarin derivatives with
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extremely high potencies. They are designed to be
antagonists of vitamin K but they are much more fat
soluble and their half lives are many weeks compared to
the 2-3 days of coumadin. The patient had a urine test
performed during the hospitalization to detect levels of
the commonly used “super-warfarins” of rodenticides like
bromodiolone and difenacoum but the test result was
negative. Three weeks into the hospitalization, a serum
assay for a specific warfarin derivative called brodifacoum
was sent to an outside laboratory. The result was positive
for 0.1µg/mL. This chemical is a second-generation
anticoagulant with a half-life of 157 days. It is retained
in tissues at high rates and can remain in organ systems
for years. The chemical is rapidly absorbed by the gut
and quickly causes gastrointestinal hemorrhage. The
mystery of how the patient ingested rodenticide was
confounded by her psychiatric history of depression and
prior suicide attempt. She repeatedly denied suicidal
ideations and the psychiatry department did not feel she
was a threat to herself at this time. Criminal investigation
was discussed but quickly dismissed when the patient
clearly expressed her desire not to pursue inquiries. The
patient was discharged on day 32 with instructions for
close follow-up.
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